À retenir
In 11 randomized trials with 395 people with fatty liver disease (MASLD), resistance exercise lowered ALT by 4.44 U/L (95% CI -8.84 to -0.03, P = 0.05) but not AST. The result sits right on the edge of significance and rests on small trials.
Study design
Revue des preuves
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Aerobic exercise is the usual advice for fatty liver, but some people cannot tolerate it. The authors reviewed whether resistance training improves liver enzymes and liver fat in people with metabolic dysfunction-associated steatotic liver disease (MASLD).
Population et méthode
Systematic review and meta-analysis of randomized controlled trials of resistance exercise in MASLD/NAFLD, searched in PubMed, Embase, the Cochrane Library, Web of Science, Scopus and CNKI from inception to 18 March 2025. Risk of bias was assessed with the Cochrane tool and pooling was done in RevMan 5.3. Registered in PROSPERO (CRD420251050504).
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1ALT (alanine aminotransferase, a liver enzyme) fell by a mean difference of 4.44 U/L (95% CI -8.84 to -0.03; P = 0.05).
- 2AST showed no significant difference (MD -0.18 U/L; 95% CI -6.70 to 6.34; P = 0.96).
- 3Among eight studies that used imaging, seven reported substantial reductions in liver fat and one reported no effect.
- 4Adherence did not differ between groups (RR 0.99; 95% CI 0.89 to 1.10; P = 0.92), and no serious adverse events were documented.
Limites et incertitude
- 1Only 11 trials with 395 participants were pooled, and the ALT confidence interval nearly touches zero, so the estimate is fragile.
- 2Liver fat results are a count of studies (seven of eight), not a pooled estimate, so the size of the benefit is unknown.
- 3The suggested minimum dose (8-10 exercises at 60%-80% of one-repetition maximum, at least three times weekly for at least 12 weeks) is the authors' reading across trials of differing designs, not a tested threshold.
- 4The abstract does not report how long benefits last; the authors call for larger, longer studies.
Mise en perspective
Strength training looks safe for people with fatty liver and may modestly improve ALT and liver fat, which makes it a reasonable option when aerobic exercise is hard. It is not shown to replace other care, and exercise plans for liver disease should be agreed with your clinician.
Vos données
A training log of sessions per week, exercises and loads is the right data to follow. Liver enzymes and liver fat come from blood tests and imaging ordered by your clinician, not from wearables, and trends across repeat tests matter more than one result.
Comprendre ce type de preuve
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Objective
The aim is to systematically assess the impact of resistance exercise on patients diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD).
Methods
Randomized controlled trials (RCTs) focusing on resistance exercise for MASLD/NAFLD were sourced from PubMed, Embase, the Cochrane Library, Web of Science, Scopus, and CNKI databases, (covering all entries from inception to 18 March 2025. The Cochrane Risk of Bias Tool was utilized for quality evaluation, and RevMan 5.3 software was used for conducting the meta-analysis.
Results
Eleven RCTs, involving 395 participants, were included in the analysis. The meta-analysis revealed that alanine aminotransferase (ALT) levels were significantly decreased (MD = -4.44 U/L, 95% CI = -8.84 to -0.03, Z = 1.98, P = 0.05). No significant difference was observed in aspartate aminotransferase (AST) levels (MD = -0.18 U/L, 95% CI = -6.70 to 6.34, Z = 0.05, P = 0.96). Among the eight imaging assessment studies, seven reported substantial reductions in liver fat content, whereas one study indicated no effect. No significant difference in clinical compliance was detected between the groups (RR = 0.99, 95% CI = 0.89 to 1.10, P = 0.92), and no serious adverse events were documented.
Conclusion
Resistance exercise notably enhances ALT levels and hepatic steatosis in patients with MASLD. The recommended minimum effective dosage is whole-body multi-muscle training, consisting of 8-10 exercises at 60%-80% of one-repetition maximum (1RM) intensity, performed at least three times weekly for a minimum of 12 weeks. This intervention is particularly advantageous for patients with elevated ALT levels who are unable to tolerate aerobic exercise, and it appears to be safe. Nonetheless, further research involving larger sample sizes is required to confirm its long-term efficacy.
Systematic review registration
https://www.crd.york.ac.uk/PROSPERO/view/CRD420251050504, identifier CRD420251050504.
Sources et attribution
Resistance training for metabolic dysfunction-associated steatotic liver disease:a systematic review and meta-analysis.
Chen Y, Qiao X, Zou X, Xu K, Gu Z, Chen G, Dai J.
Frontiers in physiology · 2026-02-02
DOI: 10.3389/fphys.2025.1679094 ↗PubMed · 41705123 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

